Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedThink Communications is a specialized medical communications agency that provides scientific and commercial strategy services to the life sciences industry. The company focuses on medical affairs, scientific platform development, publication planning, and medical education, often incorporating behavioral science into its communication strategies. MedThink serves a diverse range of pharmaceutical and biotechnology clients, helping them translate complex scientific data into actionable insights for healthcare providers. In 2022, the company was acquired by Fingerpaint Group, expanding its reach and resources within the global healthcare marketing landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedThink Communications.